GHK-Cu acts downstream at the accumulated oxidative damage cascade (Nrf2-antioxidant) and is the compound of choice for post-mitotic tissue quality, SASP suppression, and connective tissue biology
Tirzepatide has FDA approval under two brand names
The case against this recommendation The strongest version of the argument that you should not buy any home device for this, including ours, runs like this
Focus on these factors instead: Quality of the peptide (purity, proper storage, legitimate sourcing) Consistency of dosing (daily administration at similar times) Route of administration (subcutaneous is most common and effective for most uses) Adequate dosage (underdosing is more common than overdosing) Supporting recovery factors (sleep, nutrition, stress management) Ive seen people get lackluster results from improperly prepared peptides dosed perfectly, and exceptional results from high-quality BPC-157 dosed once daily
Roughly 90 per cent of drugs that show promise in animals ultimately fail in human trials
Tan X, Hu XM, Zhong XW, Chen QM, Xia QY, Zhao P